Identified variants in genes such as UGT1A7, PYCR1, LZTR1, and FAT1, which are involved in metabolic pathways, chemical carcinogenesis, MAPK signalling, and Wnt signalling, point to novel contributors to CRC in this understudied population [24–27]. This evidence concerns the gene UGT1A7 and colorectal carcinoma.